Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use

NCT04105231 is registered in ClinicalTrials.gov with Lone Baandrup as lead sponsor.

NCT NCT04105231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04105231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use
Lead sponsor
Lone Baandrup
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 1, 2021
Completion date
March 31, 2026
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dual diagnosis